Stay updated on Pembrolizumab for Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Mesothelioma Clinical Trial page.

Latest updates to the Pembrolizumab for Mesothelioma Clinical Trial page
- Check5 days agoChange DetectedAdded 'Results Submission Events (1)' and 'Revision: v3.5.2'; removed 'Revision: v3.5.0' from the history.SummaryDifference0.3%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedAddition of 'Results Submitted' and removal of 'No Results Posted' are reflected in the study record history.SummaryDifference0.1%

- Check34 days agoChange DetectedFooter revision label updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check41 days agoChange DetectedA new revision entry labeled v3.4.3 has been added to the Record History, and the previous v3.4.2 entry has been removed.SummaryDifference0.1%

- Check69 days agoChange DetectedAdded Revision: v3.4.2 to the record history. Removed the funding-lapse notice and Revision: v3.4.1 from the history.SummaryDifference0.8%

- Check76 days agoChange DetectedA government funding lapse notice was added at the top of the page. The revision history now includes Revision: v3.4.1, replacing v3.4.0.SummaryDifference0.8%

Stay in the know with updates to Pembrolizumab for Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Mesothelioma Clinical Trial page.